A Complex ICU Patient with Multi-Organ Failure

Years ago when I worked in the ICU, I had this patient and her condition was so complex. I decided that I would do a deep dive on her case and use it to teach newbies at work. Read below.

A Complex ICU Patient with Multi-Organ Failure

Patient: 71-year-old female

PM History:

• Type 2 Diabetes Mellitus, poorly controlled

• Hypertension

• Obesity (BMI 34)

• Atrial fibrillation on apixaban

• Chronic heart failure (HFrEF, EF 35%)

Presentation:

• Brought in from home after 2 days of fever, productive cough, shortness of breath, and confusion.

• Family reports she became increasingly somnolent and hypotensive.

Vitals on ICU Admission:

• Temp: 39.2°C

• HR: 135 bpm, irregularly irregular

• BP: 78/46 mmHg

• RR: 30/min

• SpO2: 82% on 10 L O2 via non-rebreather

• GCS: 12 (confused, lethargic)

Physical Exam:

• Lungs: coarse crackles bilaterally, scattered wheezes

• Heart: tachycardic, S3 present, no murmurs

• Abdomen: soft, mild hepatomegaly

• Extremities: cold, cyanotic tips

• Skin: mottled, delayed cap refill

• Neurological: drowsy, responds to verbal stimuli

Labs on Admission

• CBC: WBC 24,500 (neutrophilic)

• Lactate: 6.5 mmol/L

• Creatinine: 3.2 mg/dL (baseline 1.4)

• BUN: 60 mg/dL

• AST/ALT: 150/140 U/L

• Total bilirubin: 3.5 mg/dL

• INR: 2.1 (on apixaban, elevated due to liver dysfunction)

• Na/K/Cl: 132/5.8/102 mmol/L

• ABG on 10 L O2: pH 7.18, PaCO2 40 mmHg, PaO2 55 mmHg, HCO3 14

• Troponin I: 0.15 ng/mL (mildly elevated, may indicate demand ischemia)

Imaging

• Chest X-ray: Bilateral patchy infiltrates with early consolidation

• Bedside Echo: EF 30%, moderate global hypokinesis, no tamponade

• Ultrasound: Enlarged, hyperechoic kidneys

ICU Assessment

Problem List:

1. Septic shock (likely pneumonia)

2. Acute hypoxemic respiratory failure

3. Acute kidney injury on CKD

4. Cardiogenic compromise (HFrEF exacerbation + septic stress)

5. Liver dysfunction / early shock liver

6. Coagulopathy (likely multifactorial)

7. Hyperlactatemia (poor tissue perfusion)

8. Altered mental status (sepsis encephalopathy)

Patient Background / Comorbidities

1. Type 2 Diabetes Mellitus, poorly controlled

   • Interpretation: Chronic hyperglycemia with likely complications (microvascular: nephropathy, neuropathy; macrovascular: CAD, HF risk).

   • Significance: Increases infection susceptibility, delays wound healing, worsens sepsis outcomes, complicates glucose management in ICU.

2. Hypertension

   • Interpretation: Chronic elevated blood pressure; may cause left ventricular hypertrophy and end-organ damage.

   • Significance: Increases risk of cardiovascular instability during shock; impacts fluid resuscitation decisions (avoid fluid overload).

3. Obesity (BMI 34)

   • Interpretation: Class I obesity.

   • Significance: Alters pharmacokinetics of medications, increases risk of hypoventilation and ARDS, complicates mechanical ventilation, and venous thromboembolism risk is higher.

4. Atrial fibrillation on apixaban

   • Interpretation: Irregularly irregular heart rhythm, anticoagulated for stroke prevention.

   • Significance: Increased bleeding risk in ICU, especially with invasive lines or procedures; may need to hold or reverse anticoagulation if invasive procedures needed.

5. Chronic heart failure (HFrEF, EF 35%)

   • Interpretation: Systolic heart failure with reduced ejection fraction.

   • Significance: Lower cardiac reserve; vulnerable to shock and fluid overload; careful fluid management required; may need inotropic support.

Presenting Complaint

• Fever, productive cough, shortness of breath, confusion for 2 days

  • Interpretation: Suggests severe infection, likely pneumonia, with early sepsis affecting CNS (encephalopathy).

• Increasing somnolence and hypotension

  • Interpretation: Indicates hemodynamic instability, possible septic shock, and impaired perfusion to the brain.

Vitals on ICU Admission

1. Temp: 39.2°C → Fever; supports infection/sepsis.

2. HR 135 bpm, irregularly irregular → A-fib with RVR; high risk of hemodynamic compromise.

3. BP 78/46 mmHg → Hypotension, consistent with shock; poor organ perfusion.

4. RR 30/min → Tachypnea, possibly compensatory for metabolic acidosis or hypoxemia.

5. SpO2 82% on 10 L O2 → Severe hypoxemia, likely pneumonia-induced ARDS or pulmonary edema.

6. GCS 12 → Altered mental status, consistent with sepsis encephalopathy or hypoperfusion.

Physical Exam

1. Lungs: coarse crackles bilaterally, scattered wheezes

   • Suggest pulmonary edema or infection (pneumonia).

2. Heart: tachycardic, S3 present

   • S3 indicates volume overload / poor LV function.

3. Abdomen: soft, mild hepatomegaly

   • Could reflect congestive hepatopathy (heart failure) or early shock liver.

4. Extremities: cold, cyanotic tips; Skin: mottled, delayed cap refill

   • Peripheral hypoperfusion, hallmark of shock.

5. Neurological: drowsy, responds to verbal stimuli

   • Sepsis-associated encephalopathy, due to hypoperfusion or inflammation.

Labs on Admission

1. CBC: WBC 24,500 (neutrophilic)

   • Interpretation: Severe bacterial infection.

2. Lactate 6.5 mmol/L

   • Interpretation: High lactate → tissue hypoperfusion → marker of septic shock severity.

3. Creatinine 3.2 mg/dL (baseline 1.4) / BUN 60

   • Acute kidney injury (AKI) on CKD, likely pre-renal from shock and hypotension.

4. AST/ALT 150/140, Total bilirubin 3.5 mg/dL

   • Shock liver or sepsis-related cholestasis, impaired hepatic perfusion.

5. INR 2.1 (on apixaban)

   • Coagulopathy, partially due to anticoagulant, liver dysfunction, and sepsis.

6. Na 132, K 5.8, Cl 102 mmol/L

   • Hyponatremia → possibly fluid shifts or SIADH; hyperkalemia → kidney injury, arrhythmia risk.

7. ABG: pH 7.18, PaCO2 40, PaO2 55, HCO3 14

   • Metabolic acidosis with respiratory compensation, severe hypoxemia.

8. Troponin I: 0.15 ng/mL

   • Mild elevation → type 2 MI (demand ischemia) or septic cardiomyopathy.

Imaging

1. Chest X-ray: Bilateral patchy infiltrates with early consolidation

   • Confirms pneumonia, possible early ARDS.

2. Echo: EF 30%, moderate global hypokinesis

   • Confirms systolic heart failure, possible septic cardiomyopathy.

3. Renal ultrasound: Enlarged, hyperechoic kidneys

   • Suggests acute-on-chronic kidney disease, possibly ischemic injury.

ICU Assessment / Problem List

1. Septic shock (likely pneumonia)

   • Life-threatening infection causing hypotension, tissue hypoperfusion.

2. Acute hypoxemic respiratory failure

   • Low oxygen saturation despite high-flow O2; may require mechanical ventilation.

3. Acute kidney injury on CKD

   • Reduced clearance of toxins and medications; electrolyte derangements.

4. Cardiogenic compromise (HFrEF exacerbation + septic stress)

   • Poor cardiac reserve; may need inotropes and careful fluid management.

5. Liver dysfunction / early shock liver

   • Impaired metabolism of drugs, coagulopathy, worse prognosis.

6. Coagulopathy (multifactorial)

   • Risk of bleeding; complicates line placement, anticoagulation, procedures.

7. Hyperlactatemia

   • Marker of poor tissue perfusion; high mortality risk.

8. Altered mental status (sepsis encephalopathy)

   • Reflects hypoperfusion, hypoxia, or direct inflammatory CNS effects.

ICU Management Plan (with Rationales)

1. Airway & Breathing

• Action: Prepare for endotracheal intubation and mechanical ventilation.

• Rationale: Patient is hypoxemic, tachypneic, and altered (GCS 12) → risk of airway compromise. Mechanical ventilation will ensure oxygenation and reduce work of breathing.

• Action: Set initial ventilator settings: Volume-controlled ventilation, low tidal volume (6 mL/kg IBW), PEEP 8–10 cmH2O.

• Rationale: Protect lungs from ventilator-induced lung injury (ARDS net protocol). PEEP improves oxygenation in pulmonary edema / ARDS.

• Action: Monitor plateau pressure (<30 cmH2O).

• Rationale: Avoid barotrauma and volutrauma.

2. Circulation & Shock Management

• Action: Rapid IV fluid resuscitation with crystalloids 30 mL/kg.

• Rationale: Septic shock often causes vasodilation and hypo-perfusion; fluid bolus restores circulating volume.

• Action: Insert central venous catheter for vasopressor administration and central venous pressure monitoring.

• Rationale: Norepinephrine cannot be safely given peripherally long-term; CVP can guide fluid therapy.

• Action: Start norepinephrine infusion if hypotension persists after fluids. Target MAP ≥65 mmHg.

• Rationale: First-line vasopressor in septic shock; restores perfusion to vital organs.

• Action: Consider dobutamine if low cardiac output persists (EF 30%).

• Rationale: Inotropic support improves tissue perfusion in septic + cardiogenic shock.

3. Infection Control

• Action: Start broad-spectrum IV antibiotics immediately: e.g., vancomycin + piperacillin-tazobactam.

• Rationale: Early empiric therapy reduces mortality in sepsis; coverage for MRSA and Pseudomonas.

• Action: Obtain blood, urine, and sputum cultures before antibiotics.

• Rationale: Identify pathogen to tailor therapy while not delaying treatment.

• Action: Evaluate for source control: drainage of abscess if present, management of pneumonia.

• Rationale: Removing infection source is crucial for sepsis resolution.

4. Renal Support

• Action: Strict hourly urine output monitoring with Foley catheter.

• Rationale: Early recognition of oliguria in AKI; guides fluid and drug management.

• Action: Adjust medications for kidney function; avoid nephrotoxins.

• Rationale: Prevent further kidney injury.

• Action: Consider CRRT (continuous renal replacement therapy) if oliguric AKI or severe acidosis/hyperkalemia develops.

• Rationale: Provides hemodynamic stability while supporting renal function.

5. Liver Dysfunction & Coagulopathy

• Action: Monitor LFTs and INR daily.

• Rationale: Shock liver may worsen coagulopathy; guides transfusion decisions.

• Action: Avoid hepatotoxic drugs.

• Rationale: Prevent further liver injury in already compromised organ.

• Action: Vitamin K if INR rises significantly.

• Rationale: Correct coagulopathy safely.

6. Neurological / Sedation

• Action: Sedate for intubation (etomidate preferred if hypotensive) and maintain light sedation with propofol or dexmedetomidine.

• Rationale: Protect airway, reduce agitation, but avoid deep sedation to allow neuro assessment.

• Action: Monitor GCS and neurological status daily.

• Rationale: Detect worsening encephalopathy or delirium.

7. Metabolic / Nutritional

• Action: Start enteral nutrition via NG tube within 24–48 hrs.

• Rationale: Supports gut integrity, prevents catabolism, improves outcomes in critical illness.

• Action: Tight but safe glycemic control (140–180 mg/dL).

• Rationale: Hyperglycemia worsens infection and outcomes; avoid hypoglycemia.

• Action: Monitor electrolytes (Na, K, Mg, Phos) frequently.

• Rationale: Prevent arrhythmias and complications from critical illness.

8. Monitoring & Support

• Action: Continuous cardiac monitoring.

• Rationale: High risk for arrhythmias (A-fib, hypokalemia, septic cardiomyopathy).

• Action: Frequent lactate checks and hemodynamic monitoring (arterial line).

• Rationale: Guides resuscitation, assesses perfusion, and shock response.

• Action: Daily chest X-ray, echocardiography as needed.

• Rationale: Track pulmonary status, cardiac function, and fluid overload.

9. Communication & Family Support

• Action: Discuss prognosis, expected ICU course, and possible complications.

• Rationale: Ensure family is informed; supports shared decision-making, especially in high-mortality cases.

Summary of Interventions with Rationales

Intervention	Rationale
Intubation & mechanical ventilation	Protect airway, improve oxygenation, reduce work of breathing
Low tidal volume ventilation, PEEP	Prevent ventilator-induced lung injury
IV fluid resuscitation	Restore circulating volume in septic shock
Central venous catheter	Safe vasopressor administration, guide fluid therapy
Norepinephrine infusion	Maintain MAP ≥65 mmHg to perfuse vital organs
Dobutamine	Support cardiac output in low EF
Broad-spectrum antibiotics	Early empiric coverage reduces mortality
Culture collection	Identify pathogens to tailor therapy
Source control	Eliminate infection source
Foley & urine output monitoring	Early detection of AKI, guide interventions
CRRT	Support renal function in AKI, remove toxins
LFT and INR monitoring	Detect liver dysfunction, guide coagulation support
Sedation for intubation, light sedation	Facilitate ventilation, reduce agitation while allowing neuro checks
Enteral nutrition	Maintain gut integrity, prevent catabolism
Glycemic control	Reduce complications, improve outcomes
Electrolyte monitoring	Prevent arrhythmias and complications
Continuous cardiac monitoring	Detect arrhythmias early
Lactate and hemodynamic monitoring	Guide resuscitation, assess tissue perfusion
Family communication	Ensure informed consent, shared decision-making